CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers
- Citation:
- J Clin Oncol vol 34 (23) 2736-2742
- Year:
- 2016
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 5
- Parents:
- 693
- Children:
- None
- Pharmas:
- 80403-Bristol Myers/Enzinger; Sanofi Aventis; and Pfizer ECOG 1206- None
- Grants:
- U10 CA021115, U10 CA031946, U10 CA180821, P30 CA008748, U10 CA180850, P30 CA060553, U10 CA180882, U10 CA180820, U10 CA180867, P30 CA006927
- Corr. Author:
- Authors:
- Peter C. Enzinger Barbara Ann Burtness Donna Niedzwiecki Xing Ye Kathe Douglas David H. Ilson Victoria Meucci Villaflor Steven J. Cohen Robert J. Mayer Alan Venook Al Bowen Benson III Richard M. Goldberg
- Networks:
- CA043, CA136, LAPS-CT018, LAPS-IL036, LAPS-MA036, LAPS-NY016, LAPS-OH007
- Study
- CALGB-80403
- Multiple Studies, or Legacy Studies in Alliance Study:
- ECOG-1206
- Phases:
- 2, 2
- Keywords:
- Gic12, ORIGINAL REPORTS, Gastrointestinal Cancer